Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × veliparib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Glioblastoma 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Dexamethasone 54 daratumumab 40 Lenalidomide 32 pomalidomide 25 Bortezomib 25 carfilzomib 24 Specimen Handling 22 Biopsy 20 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 14 Calcium Dobesilate 12 talquetamab 11 iberdomide 9 fludarabine 8 dexamethasone acetate 7 dexamethasone 21-phosphate 7 auricularum 7 Nivolumab 7 trametinib 5 X-Rays 5 Melphalan 5 tocilizumab 4 elotuzumab 4 belantamab mafodotin 4 Sunitinib 4 Nuclear Medicine Department, Hospital 4 Ipilimumab 4 Crizotinib 4 selinexor 3 pertuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡